Recurrent Ovarian Germ Cell Tumor Withdrawn Phase 1 Trials for Metformin (DB00331)

IndicationStatusPhase
DBCOND0029793 (Recurrent Ovarian Germ Cell Tumor)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02050009Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerTreatment